Emily M Bucholz1, Holly C Gooding2, Sarah D de Ferranti3. 1. Department of Medicine, Boston Children's Hospital, Boston, Massachusetts. Electronic address: emilymarie.bucholz@childrens.harvard.edu. 2. Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts. 3. Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.
Abstract
INTRODUCTION: Young adults with hyperlipidemia, hypertension, and diabetes are at increased risk of developing heart disease later in life. Despite emphasis on early screening, little is known about awareness of these risk factors in young adulthood. METHODS: Data from the nationally representative cross-sectional National Health and Nutrition Examination Survey 2011-2014 were analyzed in 2017 to estimate the prevalence of self-reported awareness of hypercholesterolemia, hypertension, and diabetes in U.S. young adults aged 18-39 years (n=11,083). Prevalence estimates were weighted to population estimates using survey procedures, and predictors of awareness were identified using weighted logistic regression. RESULTS: Among U.S. young adults, the prevalence of hypercholesterolemia, hypertension, and diabetes was 8.8% (SE=0.4%); 7.3% (SE=0.3%); and 2.6% (SE=0.2%), respectively. The prevalence of borderline high cholesterol, blood pressure, and blood glucose were substantially higher (21.6% [SE= 0.6%]; 26.9% [SE=0.7%]; and 18.9% [SE=0.6%], respectively). Awareness was low for hypercholesterolemia (56.9% [SE=2.4%]) and moderate for hypertension and diabetes (62.7% [SE=2.4%] and 70.0% [SE=2.7%]); <25% of young adults with borderline levels of these risk factors were aware of their risk. Correlates of risk factor awareness included older age, insurance status, family income above the poverty line, U.S. origin, having a usual source of health care, and the presence of comorbid conditions. CONCLUSIONS: Despite the high prevalence of cardiovascular risk factors in U.S. young adults, awareness remains less than ideal. Interventions that target access may increase awareness and facilitate achieving treatment goals in young adults.
INTRODUCTION: Young adults with hyperlipidemia, hypertension, and diabetes are at increased risk of developing heart disease later in life. Despite emphasis on early screening, little is known about awareness of these risk factors in young adulthood. METHODS: Data from the nationally representative cross-sectional National Health and Nutrition Examination Survey 2011-2014 were analyzed in 2017 to estimate the prevalence of self-reported awareness of hypercholesterolemia, hypertension, and diabetes in U.S. young adults aged 18-39 years (n=11,083). Prevalence estimates were weighted to population estimates using survey procedures, and predictors of awareness were identified using weighted logistic regression. RESULTS: Among U.S. young adults, the prevalence of hypercholesterolemia, hypertension, and diabetes was 8.8% (SE=0.4%); 7.3% (SE=0.3%); and 2.6% (SE=0.2%), respectively. The prevalence of borderline high cholesterol, blood pressure, and blood glucose were substantially higher (21.6% [SE= 0.6%]; 26.9% [SE=0.7%]; and 18.9% [SE=0.6%], respectively). Awareness was low for hypercholesterolemia (56.9% [SE=2.4%]) and moderate for hypertension and diabetes (62.7% [SE=2.4%] and 70.0% [SE=2.7%]); <25% of young adults with borderline levels of these risk factors were aware of their risk. Correlates of risk factor awareness included older age, insurance status, family income above the poverty line, U.S. origin, having a usual source of health care, and the presence of comorbid conditions. CONCLUSIONS: Despite the high prevalence of cardiovascular risk factors in U.S. young adults, awareness remains less than ideal. Interventions that target access may increase awareness and facilitate achieving treatment goals in young adults.
Authors: John Z Ayanian; Alan M Zaslavsky; Joel S Weissman; Eric C Schneider; Jack A Ginsburg Journal: Am J Public Health Date: 2003-12 Impact factor: 9.308
Authors: J Stamler; R Stamler; J D Neaton; D Wentworth; M L Daviglus; D Garside; A R Dyer; K Liu; P Greenland Journal: JAMA Date: 1999-12-01 Impact factor: 56.272
Authors: Ann Marie Navar-Boggan; Eric D Peterson; Ralph B D'Agostino; Benjamin Neely; Allan D Sniderman; Michael J Pencina Journal: Circulation Date: 2015-01-26 Impact factor: 29.690
Authors: Paul Muntner; Emily B Levitan; Todd M Brown; Pradeep Sharma; Hong Zhao; Vera Bittner; Stephen Glasser; Meredith Kilgore; Huifeng Yun; J Michael Woolley; Michael E Farkouh; Robert S Rosenson Journal: Am J Cardiol Date: 2013-05-29 Impact factor: 2.778
Authors: Mark J Pletcher; Eric Vittinghoff; Anusorn Thanataveerat; Kirsten Bibbins-Domingo; Andrew E Moran Journal: PLoS One Date: 2016-05-03 Impact factor: 3.240
Authors: Holly C Gooding; Courtney A Brown; Anna C Revette; Viola Vaccarino; Jingyi Liu; Sierra Patterson; Catherine Stamoulis; Sarah D de Ferranti Journal: J Adolesc Health Date: 2020-07-02 Impact factor: 5.012
Authors: Michal Ptaszynski; Monika Zasko-Zielinska; Michal Marcinczuk; Gniewosz Leliwa; Marcin Fortuna; Kamil Soliwoda; Ida Dziublewska; Olimpia Hubert; Pawel Skrzek; Jan Piesiewicz; Paula Karbowska; Maria Dowgiallo; Juuso Eronen; Patrycja Tempska; Maciej Brochocki; Marek Godny; Michal Wroczynski Journal: Int J Environ Res Public Health Date: 2021-11-09 Impact factor: 3.390
Authors: Demilade A Adedinsewo; Amy W Pollak; Sabrina D Phillips; Taryn L Smith; Anna Svatikova; Sharonne N Hayes; Sharon L Mulvagh; Colleen Norris; Veronique L Roger; Peter A Noseworthy; Xiaoxi Yao; Rickey E Carter Journal: Circ Res Date: 2022-02-17 Impact factor: 23.213